{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:59:39Z","timestamp":1790492379173,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/jtm\/tay108","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T03:12:19Z","timestamp":1539918739000},"source":"Crossref","is-referenced-by-count":51,"title":["Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers"],"prefix":"10.1093","volume":"25","author":[{"given":"Nicole P","family":"Lindsey","sequence":"first","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalanthe A","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Fulton","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J","family":"Panella","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I","family":"Kosoy","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason O","family":"Velez","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R","family":"Krow-Lucal","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fischer","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Erin","family":"Staples","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"key\n\t\t\t\t2018111208354353700_tay108C1","volume-title":"Plotkin\u2019s Vaccines 7th edition","author":"Staples","year":"2017"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/trstmh\/tru092","article-title":"The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases","volume":"108","author":"Johansson","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C3","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C4","volume-title":"International Health Regulations","author":"World Health Organization","year":"2005","edition":"3rd edn"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.15585\/mmwr.mm6711e1","article-title":"Fatal yellow fever in travelers to Brazil, 2018","volume":"67","author":"Hamer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C6","doi-asserted-by":"crossref","first-page":"914","DOI":"10.15585\/mmwr.mm6634a5","article-title":"Notes from the field: fatal yellow fever in a traveler returning from Peru\u2014New York, 2016","volume":"66","author":"Newman","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C7","volume-title":"Yellow fever among travellers returning from South America\u201414 March 2017","author":"European Centre for Disease Prevention and Control","year":"2017"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jinf.2016.07.003","article-title":"Yellow fever virus: increasing imported cases in China","volume":"73","author":"Wang","year":"2016","journal-title":"J Infect"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C9","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.11.18-00106","article-title":"Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, July 2017 to March 2018","volume":"23","author":"Gossner","year":"2018","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C10","doi-asserted-by":"crossref","first-page":"1800240","DOI":"10.2807\/1560-7917.ES.2018.23.21.1800240","article-title":"Yellow fever in two unvaccinated French tourists to Brazil, January and March, 2018","volume":"23","author":"Oliosi","year":"2018","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C11","doi-asserted-by":"crossref","first-page":"1800471","DOI":"10.2807\/1560-7917.ES.2018.23.36.1800471","article-title":"Yellow fever cases in French Guiana, evidence of an active circulation in the Guiana Shield, 2017 and 2018","volume":"23","author":"Sanna","year":"2018","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C12","author":"Pan American Health Organization"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C13","first-page":"9","article-title":"[Duration of immunity following yellow fever vaccination.]","volume":"34","author":"Courtois","year":"1954","journal-title":"Ann Soc Belg Med Trop"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(52)90062-X","article-title":"Immunity to yellow fever nine years after vaccination","volume":"46","author":"Dick","year":"1952","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Review article: efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C16","first-page":"699","article-title":"Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine","volume":"27","author":"Groot","year":"1962","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4269\/ajtmh.1963.12.230","article-title":"Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine","volume":"12","author":"Rosenzweig","year":"1963","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C18","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C21","first-page":"796","article-title":"[Yellow fever virus 17D neutralizing antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue.]","volume":"10","author":"Gomez","year":"2008","journal-title":"Rev Salud Publica (Bogota)"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.2011.10-0496","article-title":"Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil","volume":"85","author":"de Melo","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s13149-011-0135-7","article-title":"Long-term persistence of yellow fever neutralizing antibodies in persons aged 60 years and older","volume":"104","author":"Coulange Bodilis","year":"2011","journal-title":"Bull Soc Pathol Exot"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0035-9203(44)80006-2","article-title":"Yellow fever in the recently inoculated","volume":"38","author":"Elliott","year":"1944","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C25","first-page":"1","article-title":"A fatal case of yellow fever in a European in Uganda","volume":"30","author":"Ross","year":"1953","journal-title":"East Afr Med J"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(89)91877-1","article-title":"Imported yellow fever in vaccinated tourist","volume":"334","author":"Nolla-Salas","year":"1989","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trstmh.2006.04.001","article-title":"Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998\u20132002","volume":"101","author":"Tuboi","year":"2007","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.vaccine.2003.11.002","article-title":"Isolation and characterization of wild type yellow fever in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil","volume":"22","author":"de Filippis","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C29","first-page":"269","article-title":"Vaccines and vaccination against yellow fever: WHO Position Paper\u2014June 2013","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C30","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1016\/j.vaccine.2014.07.021","article-title":"Duration of post-vaccination immunity against yellow fever in adults","volume":"32","author":"Collaborative group for studies on yellow fever vaccines","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C31","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/14760584.2016.1198259","article-title":"Questions regarding the safety and duration of immunity following live yellow fever vaccination","volume":"15","author":"Amanna","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1590\/0074-02760170347","article-title":"Single shot of 17D vaccine may not confer life-long protection against yellow fever","volume":"113","author":"Vasconcelos","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/21645515.2015.1082693","article-title":"Booster dose after 10 years is recommended following 17DD-YF primary vaccination","volume":"12","author":"Campi-Azevedo","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/1469-0691.12332","article-title":"Yellow fever revaccination guidelines change\u2014a decision too feverish?","volume":"19","author":"Grobusch","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C35","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C36","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","article-title":"Swiss HIV Cohort Study. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients","volume":"48","author":"Veit","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C38","doi-asserted-by":"crossref","first-page":"e27753","DOI":"10.1371\/journal.pone.0027753","article-title":"Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study","volume":"6","author":"Roukens","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/icb.2010.155","article-title":"Insights into human CD8 (+) T-cell memory using the yellow fever and smallpox vaccines","volume":"89","author":"Ahmed","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C40","first-page":"647","article-title":"Yellow fever vaccine booster doses: recommendations of the advisory committee on immunization practices, 2015","volume":"64","author":"Staples","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t2018111208354353700_tay108C41","author":"Advisory Committee on Immunization Practices"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jtm\/article-pdf\/25\/1\/tay108\/26499689\/tay108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T05:26:59Z","timestamp":1572154019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/tay108\/5139702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,11,12]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/tay108","relation":{},"ISSN":["1708-8305"],"issn-type":[{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018]]},"published":{"date-parts":[[2018,1,1]]}}}